FGF21 and type 2 diabetes mellitus: In terms of associations with FGF21, sodium-glucose transport protein-2 (SGLT-2) inhibitor is being used for the treatment of type 2 diabetes, with the associated mechanisms involving inhibition of glucose absorption in renal tubules.